Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (195)
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
471
Price
$69.37
Total Value
$32.67K
Shares Held After
533,779
% of Holdings
0.1%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
3,390
Price
$68.74
Total Value
$233.03K
Shares Held After
533,308
% of Holdings
0.6%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
192,500
Price
$7.41
Total Value
$1.43M
Shares Held After
3,913,952
% of Holdings
4.7%
Entrada Therapeutics, Inc. (TRDA)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
192,500
Price
$7.41
Total Value
$1.43M
Shares Held After
3,913,952
% of Holdings
4.7%
Harmony Biosciences Holdings, Inc. (HRMY)
Budur Kumar — CHIEF MEDICAL OFFICER
Shares
22,954
Price
$43.10
Total Value
$989.35K
Shares Held After
13,115
% of Holdings
63.6%
Harmony Biosciences Holdings, Inc. (HRMY)
Budur Kumar — CHIEF MEDICAL OFFICER
Shares
1,000
Price
$42.79
Total Value
$42.79K
Shares Held After
13,115
% of Holdings
7.1%
Harmony Biosciences Holdings, Inc. (HRMY)
Budur Kumar — CHIEF MEDICAL OFFICER
Shares
4,500
Price
$42.25
Total Value
$190.11K
Shares Held After
14,115
% of Holdings
24.2%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
37,000
Price
$99.20
Total Value
$3.67M
Shares Held After
744,709
% of Holdings
4.7%
Ascendis Pharma A/S (ASND)
Bodenhoff Mads — SVP&PAO
Shares
3,000
Price
$270.19
Total Value
$810.57K
Shares Held After
0
% of Holdings
100.0%
Relay Therapeutics, Inc. (RLAY)
Patel Sanjiv — Director
Shares
48,199
Price
$18.94
Total Value
$912.89K
Shares Held After
519,500
% of Holdings
8.5%
Century Therapeutics, Inc. (IPSC)
Carr Douglas — SVP Finance&Operations
Shares
254
Price
$2.05
Total Value
$520.70
Shares Held After
504,565
% of Holdings
0.1%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
17,717
Price
$18.94
Total Value
$335.56K
Shares Held After
122,851
% of Holdings
12.6%
Century Therapeutics, Inc. (IPSC)
Russotti Gregory — Chief Technology and Manufacturing Officer
Shares
534
Price
$2.05
Total Value
$1.09K
Shares Held After
511,785
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
418
Price
$504.15
Total Value
$210.73K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
701
Price
$503.33
Total Value
$352.83K
Shares Held After
324,861
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,167
Price
$502.26
Total Value
$586.13K
Shares Held After
325,562
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,221
Price
$501.17
Total Value
$611.93K
Shares Held After
326,729
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,173
Price
$500.20
Total Value
$586.73K
Shares Held After
327,950
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,018
Price
$498.77
Total Value
$507.75K
Shares Held After
329,123
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,902
Price
$498.18
Total Value
$947.53K
Shares Held After
330,141
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
300
Price
$497.05
Total Value
$149.12K
Shares Held After
332,043
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
256
Price
$495.75
Total Value
$126.91K
Shares Held After
332,343
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$494.87
Total Value
$296.92K
Shares Held After
332,599
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
144
Price
$493.98
Total Value
$71.13K
Shares Held After
333,199
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
140
Price
$492.72
Total Value
$68.98K
Shares Held After
333,343
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
220
Price
$491.04
Total Value
$108.03K
Shares Held After
333,483
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$483.90
Total Value
$96.78K
Shares Held After
333,703
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$481.91
Total Value
$19.28K
Shares Held After
333,903
% of Holdings
0.0%
Relay Therapeutics, Inc. (RLAY)
Bergstrom Donald A — President, R&D
Shares
8,530
Price
$18.97
Total Value
$161.81K
Shares Held After
399,130
% of Holdings
2.1%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
1,069
Price
$46.01
Total Value
$49.19K
Shares Held After
458,977
% of Holdings
0.2%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
7,141
Price
$45.55
Total Value
$325.31K
Shares Held After
460,046
% of Holdings
1.5%
Artiva Biotherapeutics, Inc. (ARTV)
Aslan Fred — Director
Shares
23,429
Price
$10.92
Total Value
$255.75K
Shares Held After
1,449,765
% of Holdings
1.6%
UroGen Pharma Ltd. (URGN)
Schoenberg Mark — Chief Medical Officer
Shares
871
Price
$42.92
Total Value
$37.38K
Shares Held After
59,882
% of Holdings
1.4%
UroGen Pharma Ltd. (URGN)
Smith Jason Drew — General Counsel
Shares
1,519
Price
$42.54
Total Value
$64.62K
Shares Held After
53,141
% of Holdings
2.8%
Pharvaris N.V. (PHVS)
Lu Peng — President
Shares
15,000
Price
$40.68
Total Value
$610.13K
Shares Held After
65,179
% of Holdings
18.7%
AN2 Therapeutics, Inc. (ANTX)
Readnour Robin Shane — Director
Shares
5,294
Price
$6.02
Total Value
$31.86K
Shares Held After
625,350
% of Holdings
0.8%
AN2 Therapeutics, Inc. (ANTX)
Readnour Robin Shane — Director
Shares
4,725
Price
$6.02
Total Value
$28.44K
Shares Held After
557,990
% of Holdings
0.8%
Contineum Therapeutics, Inc. (CTNM)
Stengone Carmine N. — Director
Shares
2,500
Price
$16.46
Total Value
$41.14K
Shares Held After
17,217
% of Holdings
12.7%
Inhibrx Biosciences, Inc. (INBX)
Kayyem Jon Faiz — Director
Shares
5,000
Price
$113.52
Total Value
$567.58K
Shares Held After
424,360
% of Holdings
1.2%
Dyne Therapeutics, Inc. (DYN)
Friedl-Naderer Johanna — Chief Commercial Officer
Shares
185
Price
$18.88
Total Value
$3.49K
Shares Held After
152,897
% of Holdings
0.1%
Dyne Therapeutics, Inc. (DYN)
Kerr Douglas — Chief Medical Officer
Shares
1,290
Price
$18.88
Total Value
$24.36K
Shares Held After
162,564
% of Holdings
0.8%
Dyne Therapeutics, Inc. (DYN)
Cox John — Director
Shares
5,658
Price
$18.88
Total Value
$106.82K
Shares Held After
357,507
% of Holdings
1.6%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research&Development
Shares
3,500
Price
$75.46
Total Value
$264.11K
Shares Held After
153,902
% of Holdings
2.2%
Inhibrx Biosciences, Inc. (INBX)
FORSYTH DOUGLAS — Director
Shares
2,500
Price
$114.65
Total Value
$286.62K
Shares Held After
227,064
% of Holdings
1.1%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
9,681
Price
$112.28
Total Value
$1.09M
Shares Held After
730,548
% of Holdings
1.3%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
1,219
Price
$111.88
Total Value
$136.38K
Shares Held After
720,867
% of Holdings
0.2%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
500
Price
$108.23
Total Value
$54.12K
Shares Held After
719,648
% of Holdings
0.1%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
1,100
Price
$107.12
Total Value
$117.84K
Shares Held After
719,148
% of Holdings
0.2%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
6,605
Price
$100.64
Total Value
$664.72K
Shares Held After
718,048
% of Holdings
0.9%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
5,895
Price
$99.29
Total Value
$585.34K
Shares Held After
711,443
% of Holdings
0.8%
Showing 1–50 of 195 transactions (page 1 of 4)